hydralazine has been researched along with Shock, Cardiogenic in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sladen, RN | 1 |
| Rosenthal, MH | 1 |
1 other study available for hydralazine and Shock, Cardiogenic
| Article | Year |
|---|---|
Specific afterload reduction with parenteral hydralazine following cardiac surgery.
Topics: Administration, Oral; Aged; Cardiac Output; Cardiac Surgical Procedures; Female; Hemodynamics; Human | 1979 |